Evidence map›Paper›PMID 33339304›Full record

Trial reportNutrients2020

The Effects of Vitamin D-Enriched Mushrooms and Vitamin D3 on Cognitive Performance and Mood in Healthy Elderly Adults: A Randomised, Double-Blinded, Placebo-Controlled Trial.

Ian T Zajac, Mary Barnes, Paul Cavuoto, Gary Wittert, Manny Noakes

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06846827 (A Randomised Controlled Trial to Investigate the Cognitive, Mood, Anti-inflammatory and Metabolic Effects of Chronic Oyster Mushroom Intervention in Older Adults), which is not on this map. Cited by 21 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 6 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06846827 nacompletednot on this mapstarted 2023, after this paper: background citation

A Randomised Controlled Trial to Investigate the Cognitive, Mood, Anti-inflammatory and Metabolic Effects of Chronic Oyster Mushroom Intervention in Older Adults (OYSCOG)

TypeinterventionalSponsorUniversity of ReadingRan2023 to 2024Enrolled80ConditionsCognitive Change, Mood, Metabolism, Inflammatory ResponseArmsOyster mushroom, Maltodextrin
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 6 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Content of Vitamin DMetabolites · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Safety of vitamin DEFSA journal. European Food Safety Authority · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ian T ZajacCommonwealth Scientific and Industrial Research Organisation-Health and Biosecurity, P.O. Box 10041, Adelaide 5000, Australia.
Mary BarnesCentre for Epidemiology and Biostatistics, Flinders University, Adelaide 5001, Australia.ORCID 0000-0002-7832-9151
Paul CavuotoCommonwealth Scientific and Industrial Research Organisation-Health and Biosecurity, P.O. Box 10041, Adelaide 5000, Australia.
Gary WittertFreemasons Foundation Centre for Men's Health, North Terrace, Adelaide 5000, Australia.
Manny NoakesCommonwealth Scientific and Industrial Research Organisation-Health and Biosecurity, P.O. Box 10041, Adelaide 5000, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUFlinders University · AUSouth Australian Health and Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite abundant cross-sectional evidence that low vitamin D status is associated with risk of cognitive decline in ageing, interventional evidence for benefits of vitamin D supplementation is lacking. This study was a 6 month randomised, double-blinded placebo-controlled clinical trial of the effects of vitamin D3 (D3), enhanced vitamin D2 in a mushroom matrix (D2M), standard mushroom (SM) and placebo (PL) on cognition and mood in

Indexed as

AgaricalesDietary Supplements25-Hydroxyvitamin D 2AffectCalcifediolCholecalciferolCognitionCognitive DysfunctionDouble-Blind MethodErgocalciferolsFemaleHumansMaleMiddle AgedSeasonsTreatment Outcome25-hydroxyvitamin D25-Hydroxyvitamin D 2CalcifediolCholecalciferolErgocalciferolsVitamin Dcognitive functionmoodmushroomvitamin D

Identifiers

PMID33339304
PMCPMC7766163
OpenAlexW3111788954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.